Having a Say in Shaping Brain Cancer Treatment
The EndBrainCancer Initiative wants patient concerns reflected in national treatment guidelines.
Expanding Expanded Access
An easier application process could make experimental drugs more accessible to patients in need — outside the realm of clinical trials.
Miracles Do Happen in GBM
Dellann Elliott Mydland, founder and president of the EndBrainCancer Initiative and 2016 GBM Hero, discusses how miracles do happen in the world of glioblastoma multiforme (GBM), and people survive.
Effecting Change in Glioblastoma
Could immediate access to care be the turning point?
Dellann Elliott Mydland on Testing Brain Tumor Tissue
Dellann Elliott Mydland, from the Chris Elliott Fund, discusses testing brain tumor tissue before surgery.
Clinical Trial Opportunity for Patients With Recurrent Glioblastoma
2015 started off with a bang, with a focus on brain cancer patients and new treatment options for recurrent glioblastoma (rGBM).